Welcome to the APSA Quality and Safety Committee Adhesive Small Bowel Obstruction toolkit. This toolkit is intended to help anyone who is interested in quality improvement (QI) projects related to management of adhesive small bowel obstruction.
Available toolkit projects are listed below. Many of the approaches described are evidence based - some are not. These approaches have not been approved by APSA.
Various institutions have implemented protocols for the management of adhesive small bowel obstructions. Several examples are shared below.
Cincinnati Children’s Hospital
Developed a standardized, collaborative protocol between the surgery and radiology services for the management of patients with adhesive small bowel obstruction (ABSO) .
Protocol
Resources
Stakeholders
Surgery, radiology, pharmacy
Challenges and solutions
Spread knowledge about the use of gastrografin in ASBO, gain acceptance from radiologists, establish reasonable and safe work flow for administration of gastrografin, patients not primarily on surgical service (i.e. intensive care unit patients) can provide communication challenges.
Submitted by: Beth Rymeski
Additional Implementers: Irene Isabel (Iris) Lim-Beutel
Children’s Hospital of Wisconsin
mplemented a protocol using water soluble contrast for the management of patients with ABSO which was developed collaboratively between pediatric surgery and radiology [1].
Protocol
Resources
Stakeholders
Surgery, radiology, pharmacy
Challenges and solutions
Submitted by: Kyle Van Arendonk
Additional implementers: Kevin Boyd (pediatric radiologist)
Nemours-AI duPont Hospital for Children
Uses a pathway for the use of watern soluble contrast for adhesive small bowel obstruction is also utilized. This protocol has no age limit and has been utilized in neonates.
Protocol
Resources
Stakeholders
Surgery and radiology (including radiologist and fluoroscopy technician)
Challenges and solutions
Some resistance due to concern about high osmolarity of contrast and whether this would result in fluid shifts or respiratory compromise if aspirated, especially in neonates. We have no age limit for the protocol and we have not observed any adverse events related to contrast administration, even in neonates.
Links to published data: refer to the recent research section.
IRB approval: exempt as a QI project.
Submitted by: Loren Berman
Additional implementers: Radiologists: Sharon Gould, Lauren Averill; Fluoroscopy technician: Theresa Moore
For recent research pertaining to the management of patients with adhesive small bowel obstruction, please refer to the references below [1][2][3].